Application of a Human Multidrug Transporter (ABCG2) Variant as Selectable Marker in Gene Transfer to Progenitor Cells
- 1 March 2003
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 14 (4) , 403-412
- https://doi.org/10.1089/104303403321209005
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Characterization of Drug Transport, ATP Hydrolysis, and Nucleotide Trapping by the Human ABCG2 Multidrug TransporterPublished by Elsevier ,2002
- Multidrug Resistance 1 Gene Transfer Can Confer Chemoprotection to Human Peripheral Blood Progenitor Cells Engrafted in Immunodeficient MiceHuman Gene Therapy, 2002
- Functional Characterization of the Human Multidrug Transporter, ABCG2, Expressed in Insect CellsBiochemical and Biophysical Research Communications, 2001
- The effect of multidrug-resistance 1 gene versus neotransduction on ex vivo and in vivo expansion of rhesus macaque hematopoietic repopulating cellsBlood, 2001
- Chemoprotection of Hematopoietic Cells by a Mutant P-Glycoprotein Resistant to a Potent Chemosensitizer of Multidrug-Resistant CancersHuman Gene Therapy, 2000
- Progress in Gene Therapy for Chronic Granulomatous DiseaseThe Journal of Infectious Diseases, 1999
- Correction of Respiratory Burst Activity in X-Linked Chronic Granulomatous Cells to Therapeutically Relevant Levels after Gene Transfer into Bone Marrow CD34+CellsHuman Gene Therapy, 1998
- Altered Drug-stimulated ATPase Activity in Mutants of the Human Multidrug Resistance ProteinJournal of Biological Chemistry, 1996
- Production of high-titer helper-free retroviruses by transient transfection.Proceedings of the National Academy of Sciences, 1993
- Biological Defense Mechanisms. THE PRODUCTION BY LEUKOCYTES OF SUPEROXIDE, A POTENTIAL BACTERICIDAL AGENTJournal of Clinical Investigation, 1973